Pesquisa de mercado de cuidados com os olhos

SIS International Research has an eye on the optical world, and our vision is 20/20 when it comes to providing optical companies, eye care professionals, and leisure eyewear businesses with market research insight, data, intelligence, and analysis.

In a world where eye health is becoming increasingly important due to factors like screen time and aging populations, understanding the dynamics of the eye care market is essential. How do businesses navigate this intricate landscape to deliver optimal eye care solutions? Eye care market research is usually the best tool for businesses to thrive in this market.

Eye Care Market Research: How Leading Ophthalmic Brands Win Share

Eye care market research has shifted from descriptive category tracking to decision-grade intelligence that determines launch sequencing, payer positioning, and prescriber conversion. The vertical now spans pharmaceuticals, medical devices, surgical equipment, contact lenses, and consumer optics. Each segment carries distinct buyer dynamics, regulatory pathways, and reimbursement structures. Treating them as one market produces flat strategy and missed share.

The leaders separating from the field run research as a continuous feedback loop tied to specific commercial decisions. They use eye care market research to validate indication prioritization, refine the payer value story, and pressure-test launch sequencing across geographies. The discipline rewards specificity. General ophthalmology insights rarely move the share needle in dry eye, glaucoma, retinal disease, or refractive surgery, because each subcategory has its own KOL hierarchy and patient journey.

What High-Value Eye Care Market Research Actually Measures

The strongest programs measure four variables together: prescriber preference, patient adherence, channel economics, and payer acceptance. Pulling any one out of context yields misleading conclusions. A dry eye therapy with strong ophthalmologist enthusiasm can fail at the pharmacy counter if copay friction is not modeled. A premium IOL with superior optical performance can stall if cataract surgeons cannot defend the upgrade conversation chairside.

Sophisticated buyers structure research around the commercial decision, not the product feature. SIS International’s structured expert interviews with ophthalmologists across the UK, Germany, and Spain on dry eye therapeutics found that prescriber perception of a molecule diverges sharply from actual prescribing behavior once formulary tier and patient out-of-pocket cost enter the conversation. That gap is where share is won and lost.

The Four Decisions Eye Care Research Should Inform

• Indication prioritization across dry eye, glaucoma, AMD, diabetic retinopathy, and myopia control.
• Launch sequencing by country, weighted by HTA submission timelines and reimbursement probability.
• Channel strategy spanning ophthalmologist, optometrist, retail pharmacy, and direct-to-consumer.
• Pricing architecture reconciling list price, gross-to-net, and patient assistance economics.

Why KOL Mapping in Ophthalmology Requires Subcategory Precision

KOL mapping in eye care fails when treated as a single influence network. The retina specialist driving anti-VEGF protocols at a tertiary academic center has limited influence over the cornea specialist setting dry eye standards, and almost none over the glaucoma fellowship director shaping trabecular micro-bypass adoption. Each subcategory operates with its own conference circuit, journal hierarchy, and society guidelines.

The firms gaining ground build separate influence maps per indication and weight them by guideline-writing authority, fellowship program size, and real-world prescribing volume. Bausch + Lomb, Alcon, Santen, and Novartis have each restructured medical affairs around this segmentation. Generalist KOL panels miss the mechanism by which adoption actually spreads in ophthalmology, which travels through fellowship lineage and surgical proctoring rather than national speaker bureaus.

The Patient Journey in Eye Care Has Three Hidden Friction Points

Patient journey mapping in ophthalmology surfaces three friction points that consistently distort commercial forecasts. First, the optometrist-to-ophthalmologist referral gate, which determines whether a chronic dry eye sufferer ever reaches a prescription pathway. Second, the diagnostic equipment threshold, since meibography, OCT angiography, and corneal topography availability shape which conditions get diagnosed at all. Third, the in-office sample dynamic, where physician-dispensed starter packs in dry eye and glaucoma drops materially shift first-fill behavior.

SIS International’s proprietary research in ophthalmic therapeutics indicates that patient adherence in chronic eye disease is governed less by efficacy perception and more by instillation technique, bottle ergonomics, and the chairside counseling protocol used by the prescribing practice. Real-world evidence programs that ignore these factors overstate persistence and understate switching risk.

Market Access Strategy Across Fragmented Reimbursement Systems

Eye care reimbursement varies more by country than almost any other therapeutic area. The UK weights NICE cost-effectiveness thresholds. Germany’s G-BA early benefit assessment shapes price negotiation under AMNOG. Spain operates regional formulary variation across autonomous communities. The US splits commercial pharmacy benefit, Medicare Part B for in-office injections, and Part D for self-administered therapies. A single payer value story cannot carry across these systems.

The brands building durable share construct country-specific HTA submission evidence packages and sequence launches against reimbursement probability rather than regulatory approval date. Roche, Regeneron, and Bayer have demonstrated this discipline in the anti-VEGF category, where commercial outcomes hinge on biosimilar competitive intelligence and contracting strategy as much as clinical differentiation.

The SIS Eye Care Intelligence Framework

Source: SIS International Research

Where Consumer Optics and Medical Devices Diverge

The consumer-facing side of eye care, including contact lenses, lens care solutions, and progressive eyewear, follows shopper journey analytics closer to FMCG than pharmaceuticals. Johnson & Johnson Vision, CooperVision, and EssilorLuxottica compete on assortment rationalization at independent optometry chains and on DTC channel economics through digital-first entrants. The research methods that work in surgical ophthalmology, weighted toward expert interviews and clinical observation, underperform here.

The opposite is also true. Applying consumer panel methods to surgical device decisions, such as femtosecond laser platforms or vitrectomy systems, misses the procurement committee dynamic where surgeon preference, hospital capital budget, and service contract economics interact. Across SIS International’s healthcare engagements, the most actionable ophthalmic intelligence comes from mixed methodologies that sequence qualitative depth interviews into quantitative validation, then triangulate against payer and procurement perspectives.

What Separates Leading Eye Care Market Research Programs

Three characteristics define the programs that consistently inform winning commercial moves. They are commissioned against a specific decision, not a knowledge gap. They segment by subcategory, geography, and stakeholder rather than by aggregate market size. They build longitudinal panels of ophthalmologists, optometrists, and patients that allow tracking of belief change over time, which is where early signals of share shift appear.

The brands compounding share in eye care treat market research as commercial infrastructure. They invest in continuous prescriber tracking, refresh patient journey maps as diagnostic technology evolves, and rebuild payer value stories ahead of each HTA cycle. Eye care market research done at this standard pays back in launch precision and defended share, not in slide decks.

Sobre SIS Internacional

SIS Internacional oferece pesquisa quantitativa, qualitativa e estratégica. Fornecemos dados, ferramentas, estratégias, relatórios e insights para a tomada de decisões. Também realizamos entrevistas, pesquisas, grupos focais e outros métodos e abordagens de Pesquisa de Mercado. Entre em contato conosco para o seu próximo projeto de pesquisa de mercado.